Background In the aftermath of Covid-19, some patients develop a fibrotic lung disease, ie,
post-COVID-19 lung disease (PCLD), for which we currently lack insights into pathogenesis …

SARS-CoV-2 is a global challenge due to its ability to mutate into variants that spread more
rapidly than the wild-type virus. Because the molecular biology of this virus has been studied …

Pulmonary fibrosis comprises a range of chronic interstitial lung diseases (ILDs) that impose
a significant burden on patients and public health. Among these, idiopathic pulmonary …

The contemporary lifestyle of the last decade has undeniably caused a tremendous increase
in oxidative-stress-inducing environmental sources. This phenomenon is not only connected …

The discovery and facile synthesis of a new class of sartan-like arterial antihypertensive
drugs (angiotensin receptor blockers [ARBs]), subsequently referred to as “bisartans” is …

The enormous societal impact of the ongoing COVID‐19 pandemic has been particularly
harsh for some social groups, such as the elderly. Recently, it has been suggested that …

Radiation-induced pulmonary fibrosis (RIPF) is a chronic and progressive respiratory tract
disease characterized by collagen deposition. The pathogenesis of RIPF is still unclear …

Rationale: Mesenchymal stromal cells (MSCs) may modulate inflammation, promoting repair
in coronavirus disease (COVID-19)–related acute respiratory distress syndrome (ARDS) …

Cellular senescence is a key biological process characterized by irreversible cell cycle
arrest. The accumulation of senescent cells creates a pro-inflammatory environment that can …

Objectives Age is the strongest risk factor of giant cell arteritis (GCA), implying a possible
pathogenetic role of cellular senescence. To address this question, we applied an …